Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies

INTRODUCTION: Lenvatinib is an oral multitargeted tyrosine kinase inhibitor that has shown efficacy and manageable safety across multiple cancer types. The recommended starting doses for lenvatinib differ across cancer types and indications based on whether it is used as monotherapy or as combinatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Motzer, Robert J., Taylor, Matthew H., Evans, Thomas R. Jeffry, Okusaka, Takuji, Glen, Hilary, Lubiniecki, Gregory M., Dutcus, Corina, Smith, Alan D., Okpara, Chinyere E., Hussein, Ziad, Hayato, Seiichi, Tamai, Toshiyuki, Makker, Vicky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484451/
https://www.ncbi.nlm.nih.gov/pubmed/35260027
http://dx.doi.org/10.1080/14737140.2022.2039123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484451/
https://www.ncbi.nlm.nih.gov/pubmed/35260027
http://dx.doi.org/10.1080/14737140.2022.2039123

Ejemplares similares